Neurocrine UK Limited
19
0
0
18
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Low Risk
Score: 15/100
5.3%
1 terminated/withdrawn out of 19 trials
94.7%
+8.2% vs industry average
37%
7 trials in Phase 3/4
56%
10 of 18 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (19)
Long-term Safety Study of Chronocort in the Treatment of Participants With Congenital Adrenal Hyperplasia
Role: lead
Comparison of Chronocort Versus Standard Hydrocortisone Replacement Therapy in Participants Aged 16 Years and Over With Congenital Adrenal Hyperplasia
Role: lead
A Study of the Efficacy, Safety and Tolerability of Chronocort in Treating CAH
Role: lead
Chronocort Versus Plenadren Replacement Therapy in Adults With Adrenal Insufficiency
Role: lead
Effect of Slow Release Hydrocortisone on Fed & Fasting Volunteers; Immediate Release on Fasting Only
Role: lead
Treatment of Adrenal Insufficiency in Children
Role: lead
An Investigational Study of Hydrocortisone
Role: lead
Comparison of Two Forms of Hydrocortisone in Patients With Congenital Adrenal Hyperplasia
Role: lead
Open-label Comparison of Chronocort® Versus Standard Glucocorticoid Replacement Therapy
Role: lead
Comparison of Chronocort® With Standard Glucocorticoid Therapy in Patients With Congenital Adrenal Hyperplasia
Role: lead
A Study of Chronocort® Versus Cortef ® in Healthy Adult Male Subjects
Role: lead
Study to Compare DITEST to Testosterone Undecanoate in Adult Men With Hypogonadism
Role: lead
Extension Study for Patients Entered Into Study Infacort 003
Role: lead
A Study of Infacort® Versus Cortef® in Healthy Adult Male and Female Subjects
Role: lead
Comparison of Pharmacokinetics of Infacort® Versus Immediate-release Hydrocortisone
Role: lead
Bioavailability of Infacort When Administered Onto Food Compared to Direct Oral Administration
Role: lead
Pilot Study to Characterize and Examine the Pharmacokinetics and Efficacy of Chronocort® in Adults With CAH
Role: lead
A Two-part, Study to Compare the Pharmacokinetics and Dose Proportionality of up to 6 Chronocort Formulations
Role: lead
An Open Label Study in Healthy Volunteers to Compare Chronocort® to Hydrocortisone
Role: lead
All 19 trials loaded